Synthesis of potent C2-symmetric, diol-based HIV-1 protease inhibitors.: Investigation of thioalkyl and thioaryl P1/P1′ substituents

被引：17

作者：

Mühlman, A

Classon, B

Hallberg, A

Samuelsson, B ^{[1
]}

机构：

[1] Stockholm Univ, Dept Organ Chem, Arrhenius Lab, SE-10691 Stockholm, Sweden

[2] Uppsala Univ, Dept Organ Pharmaceut Chem, BMC, SE-75123 Uppsala, Sweden

[3] Medivir AB, SE-14144 Huddinge, Sweden

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2001年 / 44卷 / 21期

关键词：

D O I：

10.1021/jm0011169

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The synthesis of novel, potent diol-based HIV-1 protease inhibitors, having either -SAr, -SCH2-Ar, or -SCH2R groups as P1/P1' substituents is described. They can be prepared using a straightforward synthesis involving a thiol nucleophilic ring opening of a diepoxide. Inhibitor 13 was found to be a potent inhibitor of HIV-1 PR, showing good antiviral activity in a cell-based assay.

引用

页码：3402 / 3406

页数：5

共 50 条

[41] Inhibitors of the C2-symmetric HIV-1 protease:: Nonsymmetric binding of a symmetric cyclic sulfamide with ketoxime groups in the P2/P2′ side chains
Hultén, J
Andersson, HO
Schaal, W
Danielson, HU
Classon, B
Kvarnström, I
Karlén, A
Unge, T
Samuelsson, B
Hallberg, A
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (20) : 4054 - 4061
[42] Novel inhibitors of HIV protease: Design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffolds
Spaltenstein, A
Almond, MR
Bock, WJ
Cleary, DG
Furfine, ES
Hazen, RJ
Kazmierski, WM
Salituro, FG
Tung, RD
Wright, LL
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (11) : 1159 - 1162
[43] A study of the interaction between HIV-1 protease and C2-symmetric inhibitors by computational methods
Shuhua Shi
Guodong Hu
Xiumei Zhang
Jihua Wang
Journal of Molecular Modeling, 2014, 20
[44] A study of the interaction between HIV-1 protease and C2-symmetric inhibitors by computational methods
Shi, Shuhua
Hu, Guodong
Zhang, Xiumei
Wang, Jihua
JOURNAL OF MOLECULAR MODELING, 2014, 20 (08)
[45] Optimization of P1-P3 groups in symmetric and asymmetric HIV-1 protease inhibitors
Andersson, HO
Fridborg, K
Löwgren, S
Alterman, M
Mühlman, A
Björsne, M
Garg, N
Kvarnström, I
Schaal, W
Classon, B
Karlén, A
Danielsson, UH
Ahlsén, G
Nillroth, U
Vrang, L
Öberg, B
Samuelsson, B
Hallberg, A
Unge, T
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2003, 270 (08): : 1746 - 1758
[46] Novel prodrug approach to amprenavir-based HIV-1 protease inhibitors via O → N Acyloxy migration of P1 moiety
Kazmierski, WM
Bevans, P
Furfine, E
Spaltenstein, A
Yang, HB
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (15) : 2523 - 2526
[47] PROTEASE INHIBITORS WITH POTENTIAL P3-P1 BRIDGING LIGANDS - SYNTHESIS OF HIV-1 PROTEASE INHIBITORS
ROMEO, S
HOUSEMAN, K
MUELLER, RA
RICH, DH
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 205 : 54 - MEDI
[48] Molecular dynamics simulation and free energy calculations of symmetric fluoro-substituted diol-based HIV-1 protease inhibitors
Chen, Jian-Zhong
Yang, Mao-You
Yi, Chang-Hong
Shi, Shu-Hua
Zhang, Qing-Gang
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2009, 899 (1-3): : 1 - 8
[49] Design and biological evaluation of novel HIV-1 protease inhibitors with isopropanol as P1′ ligand to enhance binding with S1′ subsite
Zhu, Mei
Ma, Ling
Dong, Biao
Zhang, Guoning
Wang, Juxian
Zhou, Jinming
Cen, Shan
Wang, Yucheng
BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (16) : 115623
[50] Synthesis of novel, fluorinated P1 NS3 protease inhibitors of HCV
Chen, Yan
Sit, S. Y.
Chen, Jie
Sun, Li-Qiang
D'Andrea, Stanley V.
Zheng, Zhizhen
Wang, Alan X.
Hiebert, Sheldon
Bowsher, Mike
Cocuzza, Anthony
Zhao, Qian
Bilder, Donna
Sin, Ny
Venables, Brian L.
Carini, David
Johnson, Barry
Mull, Eric
Hernandez, Dennis
Sheaffer, Amy K.
Mulherin, Heather
Yu, Fei
Knipe, Jay O.
Mosure, Kathy
Good, Andrew C.
Rajamani, Ramkumar
Klei, Herbert
Friborg, Jacques
Arora, Vinod
Shu, Yue-Zhong
Huang, Xiaohua
Levesque, L.
Li, Danshi
Zhu, J.
Adam, S.
McPhee, Fiona
Meanwell, Nicholas
Scola, Paul M.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240

← 1 2 3 4 5 →